OneWorld Health Safety and Efficacy Study of Kala-Azar Treatment in Bangladesh Moves Forward

Published: Dec 22, 2011

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--OneWorld Health (OWH), a non-profit organization dedicated to developing lifesaving medicines for neglected diseases in children, announced completion of enrollment for an effectiveness study of Paromomycin Intramuscular Injection (PMIM) as a treatment for visceral leishmaniasis (VL or kala-azar) in Bangladesh. With 120 patients enrolled, the study is investigating the safety and efficacy of treatment of kala-azar with PMIM mono-therapy in VL-endemic areas of the country.

Back to news